- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01629706
Determination of Cell Population in Solution-Induced Corneal Staining (SICS) and Symptomatic Versus Asymptomatic Lens Wearers (ABBOTSFORD)
Determination of Cell Population in SICS and Symptomatic Versus Asymptomatic Lens Wearers
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria (Phase 1):
- Full legal capacity to volunteer.
- Read and sign an informed consent form.
- Willing and able to follow instructions and maintain the appointment schedule.
- Current or previous contact lens wearer and competent to insert and remove contact lenses.
- Up-to-date spectacles.
- Other protocol-defined inclusion criteria may apply.
Inclusion Criteria (Phase 2):
- Full legal capacity to volunteer.
- Read and sign an informed consent form.
- Willing and able to follow instructions and maintain the appointment schedule.
- Up-to-date spectacles.
- Wears single vision silicone hydrogel contact lenses, following a monthly replacement schedule.
- Has worn the same lens type for a minimum of 2 months, with the exception of the 2 periods of lens wear for participants who were also in Phase 1.
- Has used the same type of cleaning solution for a minimum of 2 months.
- Currently wears brand name contact lenses and uses brand name cleaning solutions that are commercially available in Canada (no private labels).
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria (Phase 1 and 2):
- Any ocular disease.
- Systemic condition that may affect a study outcome variable.
- Use of any systemic or topical medications that may affect ocular health.
- Known sensitivity to the diagnostic pharmaceuticals to be used in the study.
- Presents with significant amounts of corneal staining.
- Current use of artificial tears and/or rewetting drops.
- Wears contact lenses on an extended (overnight) or continuous wear schedule.
- Other protocol-defined exclusion criteria may apply.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PV+ClearCare / PV+Renu (Phase 1)
Balafilcon A contact lens pre-soaked overnight in ClearCare cleaning and disinfecting system worn in 1 eye for two hours and four hours at a time, separate days, with Balafilcon A contact lens pre-soaked overnight in renu multi-purpose solution worn in the fellow eye
|
Commercially marketed silicone hydrogel contact lens
Other Names:
Commercially marketed solution for use in removing protein, cleaning, conditioning, and disinfecting contact lenses.
Other Names:
Commercially marketed hydrogen peroxide system for cleaning and disinfecting contact lenses
Other Names:
|
Experimental: Habitual (Phase 2)
Phase 2: Habitual contact lenses worn bilaterally on a daily wear basis for 4 weeks with habitual lens care
|
Commercially marketed silicone hydrogel contact lenses as prescribed by eye care practitioner, brand and power
Lens care per habitual use
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Number of Viable Epithelial Cells Collected Directly From the Ocular Surface After 2 Hours and 4 Hours of Wear, Phase 1
Time Frame: Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
The worn contact lenses were removed and epithelial (corneal) cells were collected directly from the ocular surface using an eyewash.
Immediately following the eyewash, samples were taken to a laboratory and incubated with live/ dead stains.
The number of viable (alive) cells was counted using a microscope.
Cells collected from the right and the left eye were analyzed separately.
A significant difference in viable cell count may indicate a physiological response to the contact lens and/or care regimen over time.
|
Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
Mean Number of Non-Viable Epithelial Cells Collected Directly From the Ocular Surface After 2 Hours and 4 Hours of Wear, Phase 1
Time Frame: Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash.
Immediately following the eyewash, samples were taken to a laboratory and incubated with live/dead stains.
The number of non-viable (dead) cells was counted using a microscope.
Cells collected from the right and the left eye were analyzed separately.
A significant difference in non-viable cell count may indicate a physiological response to the contact lens and/or care regimen over time.
|
Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
Mean Number of Fluorescein-Stained Epithelial Cells Collected Directly From the Ocular Surface After 2 Hours and 4 Hours of Wear, Phase 1
Time Frame: Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash.
Immediately following the eyewash, samples were taken to a laboratory.
The total number of fluorescein-stained cells was counted using a microscope.
Cells collected from the right and the left eye were analyzed separately.
A significant difference in fluorescein-stained cell count may indicate a physiological response to the contact lens and/or care regimen over time.
|
Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
Ratio of Epithelial Cells Collected Directly From the Ocular Surface and Cells Collected From the Contact Lens After 2 Hours and 4 Hours of Wear, Phase 1
Time Frame: Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
The worn contact lenses were removed, rinsed and transferred in individual glass vials.
Epithelial cells were collected directly from the ocular surface using an eyewash.
Samples were taken to a laboratory and cells collected from each lens and each eye were counted separately using a microscope.
The ratio of cells collected from the ocular surface and from the contact lens was calculated.
A higher number indicates a higher percentage of cells collected from the contact lenses relative to the total number of cells collected.
|
Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
Ratio of Viable and Non-Viable Epithelial Cells After 2 Hours and 4 Hours of Wear, Phase 1
Time Frame: Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
The worn contact lenses were removed, rinsed and transferred in individual glass vials. Epithelial cells were collected directly from the ocular surface using an eyewash. Samples were taken to a laboratory and incubated with live/dead stains. Cells collected from each lens and each eye were counted separately using a microscope. The number of viable and non-viable cells was counted using a microscope. The ratio between viable and non-viable cell counts was calculated. A higher number indicates a higher percentage of non-viable cells relative to the total cell count. |
Day 1 after 2 hours of wear; Day 7 after 4 hours of wear
|
Mean Number of Viable Epithelial Cells Collected Directly From the Ocular Surface at Day 1 and Week 4, Phase 2
Time Frame: Day 1 and Week 4
|
The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash.
Immediately following the eyewash, samples were taken to a laboratory and incubated with live/dead stains.
The number of viable cells was counted using a microscope.
Cells collected from right and left eyes were pooled.
Samples were collected after 8 hours of wear.
A significant difference in cell count may indicate a physiological response to contact lens wear due to lens age.
|
Day 1 and Week 4
|
Mean Number of Non-Viable Epithelial Cells Collected Directly From the Ocular Surface at Day 1 and Week 4, Phase 2
Time Frame: Day 1 and Week 4
|
The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash.
Immediately following the eyewash, samples were taken to a laboratory and incubated with live/dead stains.
The number of non-viable cells was counted using a microscope.
Cells collected from right and left eyes were pooled.Samples were collected after 8 hours of wear.
A significant difference in cell count may indicate a physiological response to contact lens wear due to lens age
|
Day 1 and Week 4
|
Mean Number of Epithelial Cells Collected From the Contact Lens at Day 1 and Week 4, Phase 2
Time Frame: Day 1 and Week 4
|
The worn contact lenses were removed and transferred into well plates, each containing a soaking solution.
Following a soaking duration of approximately 30 minutes, lenses were rinsed and transferred in individual glass vials.
The cell content from the lens wash was taken to a laboratory and incubated with live/dead stains.
The total number of cells (viable and non-viable) were counted using a microscope.
Cells collected from right and left lens were pooled.
Samples were collected after 8 hours of wear.
A significant difference in cell count may indicate a physiological response to contact lens wear due to lens age.
|
Day 1 and Week 4
|
Mean Number of Epithelial Cells Collected Directly From the Ocular Surface at Day 1 and Week 4, Phase 2
Time Frame: Day 1 and Week 4
|
The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash.
Immediately following the eyewash, samples were taken to a laboratory and incubated with live/dead stains.
The number of cells (viable and non-viable) was counted using a microscope.
Cells collected from right and left eyes were pooled.
Samples were collected after 8 hours of wear.
A significant difference in cell count may indicate a physiological response to contact lens wear due to lens age.
|
Day 1 and Week 4
|
Ratio of Epithelial Cells Collected Directly From the Ocular Surface and Cells Collected From the Contact Lens at Day 1 and Week 4, Phase 2
Time Frame: Day 1 and Week 4
|
The worn contact lenses were removed, rinsed and transferred in individual glass vials.
Epithelial cells were collected directly from the ocular surface using an eyewash.
Samples were taken to a laboratory and cells collected from the right and the left eye were combined; cells collected from the right and the left lens were combined.
The ratio of cells collected from the ocular surface and from the contact lens was calculated.
A higher number indicates a higher percentage of cells collected from the contact lenses relative to the total number of cells collected.
|
Day 1 and Week 4
|
Ratio of Viable and Non-Viable Epithelial Cells at Day 1 and Week 4, Phase 2
Time Frame: Day 1 and Week 4
|
The worn contact lenses were removed, rinsed and transferred in individual glass vials.
Epithelial cells were collected directly from the ocular surface using an eyewash.
Samples were taken to a laboratory and incubated with live/dead stains.
Cells collected from the right and the left eye were combined; cells collected from the right and the left lens were combined.
The number of viable and non-viable cells was counted using a microscope.
The ratio between viable and non-viable cell counts was calculated.
A higher number indicates a higher percentage of non-viable cells relative to the total cell count.
|
Day 1 and Week 4
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lyndon Jones, FCOptom, PhD, University of Waterloo School of Optometry and Vision Science
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-373-C-105
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Abbott Medical OpticsCompletedStable Myopic Refractive Error, With or Without AstigmatismUnited States
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
Clinical Trials on Balafilcon A contact lens
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismAustralia, United States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedContact LensesUnited Kingdom
-
CIBA VISIONCompleted
-
CIBA VISIONUniversity of WaterlooCompleted
-
Alcon ResearchCompletedRefractive Error | Astigmatism | Myopia
-
Alcon ResearchCompleted
-
CIBA VISIONCompleted